Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cryo-Cell Intl Inc (CCEL)

Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cryo-Cell Intl Inc 700 Brooker Creek Boulevard Suite 1800 Oldsmar FL 34677 USA

www.cryo-cell.com P: 813-749-2100

Description:

CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Key Statistics

Overview:

Market Capitalization, $K 69,455
Enterprise Value, $K 78,695
Shares Outstanding, K 8,104
Annual Sales, $ 31,340 K
Annual Net Income, $ -9,520 K
Last Quarter Sales, $ 7,850 K
Last Quarter Net Income, $ 560 K
EBIT, $ -12,300 K
EBITDA, $ -10,570 K
60-Month Beta 0.43
% of Insider Shareholders 33.80%
% of Institutional Shareholders 10.44%
Float, K 5,365
% Float 66.20%
Short Volume Ratio 0.37

Growth:

1-Year Return 69.13%
3-Year Return 5.06%
5-Year Return 25.60%
5-Year Revenue Growth 7.26%
5-Year Earnings Growth 48.39%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.07 on 04/15/24
Latest Earnings Date 04/19/24
Earnings Per Share ttm 0.44
EPS Growth vs. Prev Qtr -73.08%
EPS Growth vs. Prev Year -22.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CCEL Ratios

Ratio
Price/Earnings ttm 18.84
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.31%
Return-on-Assets % 5.47%
Profit Margin % -30.38%
Debt/Equity -1.00
Price/Sales 2.14
Price/Cash Flow 12.48
Price/Book N/A
Book Value/Share -1.25
Interest Coverage -9.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar